GM Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Sell |
499
-14
| -3% | -$6.23K | 0.01% | 268 |
|
|
2025
Q1 | $249K | Hold |
513
| – | – | 0.01% | 235 |
|
|
2024
Q4 | $207K | Sell |
513
-7
| -1% | -$2.82K | 0.01% | 247 |
|
|
2024
Q3 | $242K | Buy |
520
+14
| +3% | +$6.51K | 0.01% | 221 |
|
|
2024
Q2 | $237K | Sell |
506
-31
| -6% | -$14.5K | 0.02% | 205 |
|
|
2024
Q1 | $224K | Buy |
+537
| New | +$224K | 0.02% | 207 |
|
|
2023
Q4 | – | Sell |
-799
| Closed | -$278K | – | 209 |
|
|
2023
Q3 | $278K | Buy |
+799
| New | +$278K | 0.02% | 163 |
|